MoneyWorks4Me

Lupin informs about press release

28 Sep 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 28th September 2020 as regards launch by the Company of Fosaprepitant for Injection, 150 mg Single-Dose Vial, having received an approval from the US FDA earlier.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..